Medicare Coverage - General Information

Date
10/19/2009
Text to display
N/A
Subject
AHRQ Draft TA for review
Content
Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment

The Agency for Healthcare Research and Quality's (AHRQ) Technology Assessment Program will be posting a draft technology assessment for review on October 26, 2009. This draft is entitled "Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment." If you are interested in reviewing this document, please visit: http://www.ahrq.gov/clinic/ta/tareview.htm. The document will be available for review from 9:00 AM on October 26, 2009 to 5:00 PM November 9, 2009. If you have any questions, please contact ahrqtap@ahrq.hhs.gov.